IL28058A - Preparation of an anti-rh gamma globulin - Google Patents

Preparation of an anti-rh gamma globulin

Info

Publication number
IL28058A
IL28058A IL28058A IL2805867A IL28058A IL 28058 A IL28058 A IL 28058A IL 28058 A IL28058 A IL 28058A IL 2805867 A IL2805867 A IL 2805867A IL 28058 A IL28058 A IL 28058A
Authority
IL
Israel
Prior art keywords
precipitate
iii
solution
preparation
supernatant
Prior art date
Application number
IL28058A
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of IL28058A publication Critical patent/IL28058A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

PATENT ATTORNEYS 1 REINHOLD COHN MICHAEL COHN ISRAEL SHACHTER C PATENTS AND DESIGNS ORDINANCE SPECIFICATION Preparation of an globulin ORTHO corporation of the State of New of Hew do hereby declare the nature of this invention and in what manner the same is to be to be particularly described and ascertained in and by the following statement 163 plasminogen and Supernatant III consists principally o gamma globulins and minor amounts of fibrinogen and The final step of the fractionation yields Precipitate which is essentially pure gamma G globulin almost completely free of 19 S and lipids Precipitate II prepared by the the inventio an gamm The may more fully understood with ence to the following Human blood plasma is cooled to The plasma is centrifuged in a Sharpies with in at feeding at the rate 1000 per The cold insoluble precipitate is The of the natant adjusted to The methanol content of the batc is brought to the addition of 177 methanol per liter of The solution is stirred slow at for one hour and is maintained at The solution is centrifuged in a Sharpies trifuge with in at feeding at the of 1000 100 per Supernatant I is collected in bowl equipped with To each liter of Supernatant I there is with 601 of of 10 acetic and of 4 sodium aceta This brings the methan concentration to the strength to and the pH to The solution is brought to a temperature of and is stirred alowly for two The solution is then allowed to stand for 16 times weight o Preoipitate II III of To the 5 suspension added 2 volumes weight of Precipitate III of sodium A further 1 1 time ieight of Preoipitate II III of water containing of acetate buffer for each gram of Precipitate II III The acetate buffer is prepared by diluting 40 o 10 acid and 20 of 4 sodium acetate to 100 with distilled The pH of the solution is The solution is stirred slowly for one There is then added volumes times the original weight of Precipitate II III of ice water and volumes times the original weight of Precipitate II of methanol while maintaining the temperature at The solution is stirred slowly for one hour and allowed stand The solution contains methanol and has a pH of and an ionic strength The solution is centrifuged in a Sharpies trifuge with a at a temperature of and at a flow rate o 500 50 per The volume 6f Supernatant III is Precipitate III is Supernatant III treated with V 512 and is stirred for 20 The is filtered through an filter press containing An acetate buffer of pH made up as 25 sodium acetate and 3 10 acetic acid made up to 100 with distilled The acetate buffer is diluted 100 times with This solutio has an ionic strength of An Eitel filter press is precoated with the acetate buffer plus Cellte 512 gm of pad using 40 of inch of pad surface Supernatant III is filtered and to the filtrate is added of sodium chloride and of 1 bicarbonate per lite o filtered Supernatant The pH of insufficientOCRQuality

Claims (1)

1. 20 and onic strength being between and 21 gi llter and separating from the resulting liquid system a fourth i 22 precipitate and a fourth 23 adding methanol to said fourth precipitate and 24 adjusting the temperature to about the amount of said methano 25 being between and the pH being between and and the strength being between and and 27 separating from the resulting liquid system a fifth precipitate 28 a fifth 29 adding methanol to said fifth supernatant and 30 adjusting the temperature to about the amount of said methanol being between and the pH being between 32 and and the ionic strength being between and 33 and separating said resulting liquid system into a sixth precipita 34 and a sixth A method according to Claim wherein said sixth precipitate is insufficientOCRQuality
IL28058A 1966-06-03 1967-05-29 Preparation of an anti-rh gamma globulin IL28058A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55517566A 1966-06-03 1966-06-03

Publications (1)

Publication Number Publication Date
IL28058A true IL28058A (en) 1971-08-25

Family

ID=24216259

Family Applications (1)

Application Number Title Priority Date Filing Date
IL28058A IL28058A (en) 1966-06-03 1967-05-29 Preparation of an anti-rh gamma globulin

Country Status (14)

Country Link
US (1) US3449314A (en)
BE (1) BE699251A (en)
CH (1) CH543886A (en)
CS (1) CS154570B2 (en)
DE (1) DE1617718A1 (en)
DK (1) DK114996B (en)
ES (1) ES341266A1 (en)
FI (1) FI47374C (en)
GB (1) GB1163493A (en)
GR (1) GR32294B (en)
IL (1) IL28058A (en)
NL (1) NL6707646A (en)
NO (1) NO122991B (en)
SE (1) SE331886C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
DE2624373C2 (en) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Process for the production of sterile filtered cryoprecipitate with an enrichment of factor VIII
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
AU784808B2 (en) * 2001-04-02 2006-06-29 Kedrion Melville Inc. Prion and viral clearance process
CN100507567C (en) 2002-05-23 2009-07-01 奥索临床诊断有限公司 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US2761808A (en) * 1952-09-06 1956-09-04 Ortho Pharma Corp Plasma fractionation process
US2761811A (en) * 1954-07-22 1956-09-04 Ortho Pharma Corp Preparation of blood fraction for use in rh testing procedures
US2761810A (en) * 1954-07-22 1956-09-04 Ortho Pharma Corp Preparation of blood fraction for use in rh testing procedures
US2761809A (en) * 1954-07-22 1956-09-04 Ortho Pharma Corp Preparation of blood fraction for use in rh testing procedures
US2790790A (en) * 1954-11-10 1957-04-30 Swift & Co Protein fractionation
US3361732A (en) * 1964-07-28 1968-01-02 Dow Chemical Co Method for concentration of blood protein solutions employing methanol and flash evaporation

Also Published As

Publication number Publication date
ES341266A1 (en) 1968-06-16
CH543886A (en) 1973-11-15
CS154570B2 (en) 1974-04-30
DE1617718A1 (en) 1971-07-15
GB1163493A (en) 1969-09-04
SE331886B (en) 1971-01-18
SE331886C (en) 1974-01-28
FI47374B (en) 1973-07-31
DK114996B (en) 1969-08-25
US3449314A (en) 1969-06-10
NO122991B (en) 1971-09-13
BE699251A (en) 1967-11-30
NL6707646A (en) 1967-12-04
FI47374C (en) 1973-11-12
GR32294B (en) 1967-06-08

Similar Documents

Publication Publication Date Title
US7125552B2 (en) Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
Booyse et al. In vitro incorporation of amino-acids into the contractile protein of human blood platelets
JPH0231687A (en) Purification of serum albumin
US4332717A (en) Purification of human growth hormone
IL28058A (en) Preparation of an anti-rh gamma globulin
IE56981B1 (en) Purification of interferon
US2793203A (en) Process of preparing stable, highly purified gamma globulin preparations
JPH0533239B2 (en)
US4476109A (en) Method of preparing gamma globulin suitable for intravenous administration
US4075197A (en) Serum albumin production
Saunders Venom of the stonefish Synanceja verrucosa
Ito et al. Purification, crystallization, and properties of bovine milk catalase
US3003918A (en) Production of ceruloplasmin in a purified state from blood plasma fractions
Carlström The heterogeneity of lactoperoxidase
US4018885A (en) Steroid-binding globulin and process for preparing it and antibodies thereto
US5391713A (en) Interferon purification process
BG96578A (en) METHOD FOR OBTAINING PURIFIED LYSOZYME DIMERS
Taylor et al. An improved procedure for the preparation of human serum albumin from placental extracts
CN110467664A (en) A method of isolating and purifying serum globulins
FUNATSU et al. Structure and Toxic Function of Ricin I Purification Procedures of Ricin D
DE2014957C2 (en) Process for purifying proteins from blood serum or plasma
DE3279292D1 (en) Blood fractionation improvement
Van Regenmortel Purification of a watermelon mosaic virus
Manderino et al. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography
US2957809A (en) Insulinase